您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (10): 20-24.doi: 10.6040/j.issn.1671-7554.0.2014.284

• 基础医学 • 上一篇    下一篇

HSP70/CD80 DNA疫苗通过调节Th1/Th2/Treg/Th17细胞对小鼠急性哮喘的抑制作用

李燕1, 谢敏2, 史小玲1, 王晓燕1, 唐利1, 钟森3, 陈庄1   

  1. 1. 泸州医学院附属医院医学实验中心, 四川 泸州 646000;
    2. 成都华西海圻医药科技有限公司, 四川 成都 610041;
    3. 成都中医药大学附属医院, 四川 成都 610075
  • 收稿日期:2014-05-04 修回日期:2014-09-19 出版日期:2014-10-10 发布日期:2014-10-10
  • 通讯作者: 陈庄。E-mail:chen917744799@qq.com E-mail:chen917744799@qq.com
  • 基金资助:
    四川省科技厅科技支撑计划(2011SZ0015);四川省科技厅应用基础研究项目(2009JY0076)

Hsp70/CD80 DNA vaccine inhibits asthma by regulating the balance of Th1/Th2/Treg/Th17 in an acute mouse model

LI Yan1, XIE Min2, SHI Xiaoling1, WANG Xiaoyan1, TANG Li1, ZHONG Sen3, CHEN Zhuang1   

  1. 1. Molecular Medicine Experimental Center, Affiliated Hospital of Luzhou Medicine College, Luzhou 646000, Sichuan, China;
    2. WestChina-Frontier Pharmaceutical Technology Company, Chengdu 610041, Sichuan, China;
    3. Affiliated Hospital of Chengdu University of TCM, Chengdu 610075, Sichuan, China
  • Received:2014-05-04 Revised:2014-09-19 Online:2014-10-10 Published:2014-10-10

摘要: 目的 考察热休克蛋白70(HSP70)/CD80 DNA疫苗治疗小鼠急性哮喘的疗效,研究该过程中Th1/Th2/Treg/Th17再平衡的作用机制。方法 BALB/c小鼠40只随机分为空白对照组(空白组),哮喘模型组(模型组),pVAX1(+)空载体对照组(空载组)和HSP70/CD80疫苗治疗组(治疗组),每组10只。鸡卵清蛋白(OVA)激发致敏小鼠构建急性哮喘模型,HSP70/CD80 DNA疫苗进行治疗。吸入性支气管激发试验测定气道反应性,ELISA法测定血清中IgE的含量,HE和AB-PAS染色观察肺组织病理学改变,ELISA法观察支气管肺泡灌洗液中γ-干扰素(IFN-γ)、白细胞介素-4(IL-4)、转化生长因子β(TGF-β)和白细胞介素-17(IL-17)等细胞因子的含量变化,实时荧光定量PCR观察肺组织中T-bet、GATA连接蛋白3(GATA-3)、叉头蛋白3(Foxp3)和维甲酸受体相关孤儿受体(RORγt)等转录因子的表达。结果 与模型组相比,DNA疫苗治疗后小鼠气道反应性明显下降(P<0.05),IgE浓度降低(P<0.05),肺组织炎症浸润减少,杯状细胞增生不明显,IFN-γ/IL-4和TGF-β/IL-17比值升高(P均<0.05),T-bet/GATA-3和Foxp3 /RORγt比值升高(P均<0.05)。结论 HSP70/CD80 DNA疫苗可能通过改变IFN-γ/IL-4和TGF-β/IL-17的比值、T-bet/GATA-3和Foxp3/RORγt的比值,使Th1/Th2/Treg/Th17恢复平衡,从而发挥对哮喘的治疗作用。

关键词: CD4+CD25+调节性T细胞, 辅助性T细胞17, 哮喘

Abstract: Objective To explore the mechanism of Th1/Th2/Treg/Th17 rebalance in an acute asthma mouse model treated with heat shock protein70 (Hsp70)/CD80 DNA vaccine. Methods Forty BALB/c mice were divided into the control group, asthma-model group, pVXA1-vector group and vaccine treatment group, 10 in each group. They were intraperitoneally injected into ovalbumin (OVA) to build acute asthma model and treated with DNA vaccine. The airway responsiveness was evaluated after inhaling the methacholine(Mch). The IgE content in serum was detected by ELISA. The pathological change of lung tissue was observed by HE and AB-PAS staining. The expressions of interferon-γ(IFN-γ), interleukin-4 (IL-4), ransforming growth factor beta (TGF-β) and interleukin-17 (IL-17) in BALF were measured by ELISA. The expressions of T-bet, GATA binding protein 3 (GATA-3), forkheah box protein3 (Foxp3) and retinoid related orphan receptor gamma t (RORγt) in lung tissue were detected by Real-time PCR. Results Compared with asthmatic mouse, mouse treated with vaccine exhibited the decreased airway responsiveness, IgE (all P<0.05) and inflammatory infiltration of lung tissues, repressed proliferation of goblet cells, and increased IFN-γ/IL-4, TGF-β/IL-17, T-bet/GATA-3 and Foxp3/RORγt (all P<0.05). Conclusion The Hsp70/CD80 DNA vaccine plays a therapeutic role in asthma by restoring the balance of Th1/Th2/Treg/Th17 cell.

Key words: CD4+CD25+ Regulatory T cell, T helper cell 17, Asthma

中图分类号: 

  • R392.9
[1] Pelaia G, Vatrella A, Maselli R. The potential of biologics for the treatment of asthma[J]. Nat Rev Drug Discov, 2012, 11(12): 958-972.
[2] 成争艳, 史小玲, 何光彤, 等.热休克蛋白70/CD80嵌合疫苗对支气管哮喘小鼠的影响[J].中华结核和呼吸杂志, 2009, 32(9):716-717.
[3] 李燕, 郭宇, 史小玲, 等. HSP70/CD80 DNA疫苗通过调节趋化因子及受体对哮喘小鼠气道炎症的作用[J]. 中华微生物学与免疫学杂志, 2013, 33(2): 123-128. LI Yan, GUO Yu, SHI Xiaoling, et al. The effect of HSP70/CD80 DNA vaccine on airway inflammation by regulating the chemokine and the receptor of chemokine in asthmatic mice[J]. Chin J Microbiol Immunol, 2013, 33(2):123-128.
[4] 李晖, 史小玲, 钟森, 等.hsp70/CD80嵌合DNA真核表达质粒的构建及鉴定[J].中华结核和呼吸杂志, 2002, 25(4): 244-245.
[5] Tanaka H, Masuda T, Tokuoka S, et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma[J]. Inflamm Res, 2001, 50(12): 616-624.
[6] McMillan S J, Xanthou G, Lloyd C M. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway[J]. J Immunol, 2005, 174(9): 5774-5780.
[7] Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice[J]. Am J Respir Crit Care Med, 2008, 178(10): 1023-1032.
[8] Wachstein J, Tischer S, Figueiredo C, et al. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells[J]. PLoS One, 2012, 7(12): 51747-51777.
[9] Barnes M J, Griseri T, Johnson A M, et al. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria[J]. Mucosal Immunol, 2013, 6(2): 324-334.
[10] Bouguermouh S, Fortin G, Baba N, et al. CD28 co-stimulation down regulates Th17 development[J]. PLoS One, 2009, 4(3): 5087-5117.
[11] Maier E, Duschl A, Horejs-Hoeck J. STAT6-dependent and -independent mechanisms in Th2 polarization[J]. Eur J Immunol, 2012, 42(11): 2827-2833.
[12] Lohoff M, Mak T W. Roles of interferon-regulatory factors in T-helper-cell differentiation[J]. Nat Rev Immunol, 2005, 5(2): 125-135.
[13] Oestreich K J, Weinmann A S. T-bet employs diverse regulatory mechanisms to repress transcription[J]. Trends Immunol, 2012, 33 (2): 78-83.
[14] Oboki K, Ohno T, Saito H, et al. Th17 and allergy[J]. Allergol Int, 2008, 57(2): 121-134.
[15] 李洧, 叶茜, 高顺翠, 等. 白细胞介素17抗体对哮喘小鼠中性粒细胞的影响[J]. 山东大学学报:医学版, 2009, 47(3): 43-47. LI Wei, YE Qian, GAO Shuncui, et al. Effects of IL-17 neutralization antibody on polymorph-nuclear of asthma in mice[J]. Journal of Shandong University: Health Sciences, 2009, 47(3): 43-47.
[1] 张秋萍,朱慧志,吕川,夏咏琪,张秀. 基于生物信息学分析鉴定哮喘潜在的关键自噬和铁死亡相关基因[J]. 山东大学学报 (医学版), 2026, 64(1): 74-87.
[2] 张政,王建伟,杨玉娟,张宇,宋西成. 哮喘儿童2008及2019年免疫球蛋白E变化及相关危险因素[J]. 山东大学学报 (医学版), 2025, 63(7): 32-36.
[3] 曹洛菲,王珊珊,王金荣,姜荷云,苗瑜,马光增. 哮喘发作期FeNO升高儿童肺功能舒张试验的特点分析[J]. 山东大学学报 (医学版), 2025, 63(6): 38-44.
[4] 孙丛丛,崔文静,张锦涛,张东,刘晓菲,潘云,亓倩,徐嘉蔚,曾荣,郭红喜,董亮. 铁死亡在支气管哮喘气道重塑中的作用[J]. 山东大学学报 (医学版), 2024, 62(7): 1-9.
[5] 王静,刘晓菲,曾荣,许长娟,张锦涛,董亮. 基于机器学习算法鉴定哮喘的坏死性凋亡相关生物标志物[J]. 山东大学学报 (医学版), 2024, 62(7): 21-32.
[6] 闫金燕,杨春,李雷,吴福玲,焦永莉,张晓蔚,李晶,张瑞珍,王磊,马香. 山东省儿童百日咳感染与哮喘的相关性[J]. 山东大学学报 (医学版), 2024, 62(7): 33-41.
[7] 丁伊人,刘婉莹,姚蕾,姚欣. 大环内酯类抗生素治疗哮喘的研究进展[J]. 山东大学学报 (医学版), 2024, 62(5): 21-27.
[8] 王婷,张丽,王刚. 神经心理性哮喘[J]. 山东大学学报 (医学版), 2024, 62(5): 28-34.
[9] 徐芳,田国雄,孙倍倍,陈馨怡,陈高莹,张睿琦,应颂敏,吴妙莲,张超,吴优倩. 重度哮喘的生物与细胞疗法研究进展[J]. 山东大学学报 (医学版), 2024, 62(5): 35-42.
[10] 石硕川,曾荣,张锦涛,张东,潘云,刘晓菲,许长娟,王莹,董亮. 基于生物信息学探索支气管哮喘中的潜在差异免疫基因和免疫浸润特征[J]. 山东大学学报 (医学版), 2024, 62(5): 43-53.
[11] 张锦涛,董亮. 气道上皮及其源性细胞因子与哮喘:思考与展望[J]. 山东大学学报 (医学版), 2024, 62(5): 1-6.
[12] 田欣鑫,王立俊,李琳,孙正达,刘海燕. CD300c-Ig对小鼠关节损伤的影响及机制[J]. 山东大学学报 (医学版), 2024, 62(2): 29-35.
[13] 徐新军,邵丽婷,陈颖,刘会芳,杨玉娟,张宇,王浛睿,宋西成. SYN008与Xolair®对过敏性哮喘小鼠治疗作用效果比较:炎症与重塑[J]. 山东大学学报 (医学版), 2024, 62(12): 1-10.
[14] 浩妍,崔丽梅,陈颖,杨玉娟,宋西成. 代谢组学在气道炎症性疾病中的应用[J]. 山东大学学报 (医学版), 2024, 62(12): 117-124.
[15] 步美玲,王金荣,冯梅,孙立锋. FOXM1在呼吸道病毒感染致哮喘小鼠急性发作中的机制[J]. 山东大学学报 (医学版), 2023, 61(6): 1-9.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!